Navigation

Investiment.io
Financial analysis platform

AbbVie Inc.

ABBV โ€ข NYSE

$294.55
โ–ผ0.48 (0.16%)โ€ข REGULAR

AbbVie Inc.

$294.55
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
โš–๏ธ

Balance SheetABBV

Balance Sheet Summary

Key balance sheet metrics and financial position for ABBV

๐Ÿข
Total Assets
$133,960,000
(in thousands USD)
๐Ÿ“‹
Total Liabilities
N/A
(in thousands USD)
๐Ÿ‘ฅ
Shareholders' Equity
-$3,270,000
(in thousands USD)
โš–๏ธ
Debt-to-Equity Ratio
-19.73
Long-term Debt / Equity

Balance Sheet Analysis

Analyze assets, liabilities, and equity trends over time

Period:annual

Select Metrics to Compare (4 selected)

Total Assets Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$40.00B$80.00B$120.00B$160.00B-6%-4%-2%0%+2%
  • Total Assets
  • Total Assets YoY Growth

Total Liabilities Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$1.00K$2.00K$3.00K$4.00K
  • Total Liabilities
  • Total Liabilities YoY Growth

Total Shareholders' Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-6.00B$0.00K$6.00B$12.00B$18.00B-210%-140%-70%0%+70%
  • Total Shareholders' Equity
  • Total Shareholders' Equity YoY Growth

Cash and Cash Equivalents Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.003500000000.007000000000.0010500000000.0014000000000.00-60%-30%0%+30%+60%
  • Cash and Cash Equivalents
  • Cash and Cash Equivalents YoY Growth